|
|
||||||||
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615
We have previously shown that a selective
increase of 84 pmol/l in either arterial or portal vein insulin
(independent of a change in insulin in the other vessel) can suppress
tracer-determined glucose production (TDGP) and net hepatic glucose
output (NHGO) by ~50%. In the present study we investigated the
interaction between equal increments in arterial and portal vein
insulin in the suppression of TDGP and NHGO. Isotopic
([3-3H]glucose) and
arteriovenous difference methods were used in conscious overnight
fasted dogs. A pancreatic clamp was used to control the endocrine
pancreas. A 40-min basal period was followed by a 180-min test period,
during which arterial and portal vein insulin levels were
simultaneously and equally increased 102 pmol/l. Hepatic sinusoidal
glucagon levels remained unchanged, and euglycemia was maintained by
peripheral glucose infusion. TDGP was suppressed ~60% by the last 30 min of the experimental period. In contrast, NHGO was suppressed 100%
by that time. Coincidentally, hepatic glucose uptake (net hepatic
[3H]glucose balance)
increased significantly (~4
µmol · kg
1 · min
1).
The effects of simultaneous equal increases in peripheral and portal
venous insulin were not additive in the suppression of TDGP. However,
they were additive in decreasing NHGO as a result of an increase in the
uptake of glucose by the liver.
conscious dog; hepatic glucose uptake
This article has been cited by other articles:
![]() |
E. Rother, A. C. Konner, and J. C. Bruning Neurocircuits integrating hormone and nutrient signaling in control of glucose metabolism Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E810 - E816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grubert, M. Lautz, D. B. Lacy, M. C. Moore, B. Farmer, A. Penaloza, A. D. Cherrington, and O. P. McGuinness Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E232 - E240. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gupta, H. Sandhu, T. Goh, K. Shah, S. R. Wiesenthal, H. Yoshii, V. Chong, T. K. T. Lam, C. A. Haber, W. Williams, et al. Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1002 - E1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Coker, D. B. Lacy, M. G. Krishna, and D. H. Wasserman Splanchnic glucagon kinetics in exercising alloxan-diabetic dogs J Appl Physiol, May 1, 1999; 86(5): 1626 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zierler Whole body glucose metabolism Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E409 - E426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Moore, P. J. Flakoll, P.-S. Hsieh, M. J. Pagliassotti, D. W. Neal, M. T. Monohan, C. Venable, and A. D. Cherrington Hepatic glucose disposition during concomitant portal glucose and amino acid infusions in the dog Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E893 - E902. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |